Extensive Intra-tumor Heterogeneity in Primary Human Glial Tumors as a Result of Locus Non-specific Genomic Alterations
暂无分享,去创建一个
Seyed E. Hasnain | Chitra Sarkar | C. Sarkar | S. Hasnain | A. Mahapatra | S. Sinha | A. Dinda | P. Chattopadhyay | Subrata Sinha | Anjan Misra | Parthaprasad Chattopadhyay | Amit K. Dinda | Ashok K. Mahapatra | S. E. Hasnain | A. Misra
[1] S. Coons,et al. Regional heterogeneity in the DNA content of human gliomas , 1993, Cancer.
[2] G. Heppner. Tumor heterogeneity. , 1984, Cancer research.
[3] W. Shapiro,et al. BCNU-sensitivity in parental cells and clones from four freshly resected near-diploid human gliomas: An astrocytoma, an anaplastic astrocytoma and two glioblastomas multiforme , 1993, Journal of Neuro-Oncology.
[4] S. Wright,et al. The shifting balance theory and macroevolution. , 1982, Annual review of genetics.
[5] A. Velázquez,et al. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Shapiro,et al. Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. , 1981, Cancer research.
[7] J. Ellis,et al. Heteroduplex molecules formed between allelic sequences cause nonparental RAPD bands. , 1994, Nucleic acids research.
[8] G. Capellá,et al. Assessment of genomic damage in colorectal cancer by DNA fingerprinting: prognostic applications. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] S. Coons,et al. Regional Heterogeneity in the Proliferative Activity of Human Gliomas as Measured by the Ki‐67 Labeling Index , 1993, Journal of neuropathology and experimental neurology.
[10] Han Mk,et al. Genetic analysis using random amplified polymorphic DNA markers. , 1993 .
[11] R. Humphrey,et al. Differential response by human melanoma cells to 1,3-bis-(2-chloroethyl)-1-nitrosourea and bleomycin. , 1973, Mutation research.
[12] J. Hallervorden. [Tumors of the nervous system]. , 1951, Strahlentherapie.
[13] D. Dexter,et al. Clinical and pharmacological implications of cancer cell differentiation and heterogeneity. , 1979, Biochemical pharmacology.
[14] I. Fidler,et al. Biological and experimental consequences of the zonal composition of solid tumors. , 1981, Cancer research.
[15] A. Jeffreys,et al. Detection of somatic changes in human cancer DNA by DNA fingerprint analysis. , 1987, British Journal of Cancer.
[16] C. Daumas-Duport,et al. Postoperative radiotherapy of supratentorial low-grade gliomas. , 1989, International journal of radiation oncology, biology, physics.
[17] G. Caetano-Anollés,et al. DNA Amplification Fingerprinting Using Very Short Arbitrary Oligonucleotide Primers , 1991, Bio/Technology.
[18] W. Whong,et al. Detection of genomic instability in lung cancer tissues by random amplified polymorphic DNA analysis. , 1998, Carcinogenesis.
[19] J. Moringlane,et al. Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. , 1999, Journal of neuropathology and experimental neurology.
[20] D. Tarin,et al. DNA fingerprinting survey of various human tumors and their metastases. , 1992, Cancer research.
[21] R Carrozzo,et al. Dinucleotide repeat polymorphism mapping to the critical region for lissencephaly (17p13.3). , 1993, Human molecular genetics.
[22] S. Baylin,et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 , 1995, Nature Genetics.
[23] P. Edwards. Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies. , 1985, British Journal of Cancer.
[24] W. Paulus,et al. Intratumoral histologic heterogeneity of gliomas. A quantitative study , 1989, Cancer.
[25] J. Serth,et al. Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 gene. , 1993, Clinical chemistry.
[26] J. Williams,et al. Genetic analysis using random amplified polymorphic DNA markers. , 1993, Methods in enzymology.
[27] F. Miller,et al. Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor. , 1980, Cancer research.
[28] S. Goldman,et al. Regional glucose metabolism and histopathology of gliomas: A study based on positron emission tomography‐guided stereotactic biopsy , 1996, Cancer.
[29] C. Marshall,et al. γ-Glutamyltranspeptidase and the ras-induced Transformation of a Rat Liver Cell Line , 1986 .
[30] S. Coons,et al. Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. , 1995, Cancer research.
[31] M. Micheli,et al. Randomly amplified polymorphic DNA fingerprinting using combinations of oligonucleotide primers. , 1993, BioTechniques.
[32] C. Daumas-Duport,et al. Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases , 1997, Journal of Neuro-Oncology.
[33] F. Mitelman,et al. The chromosomes of fifty primary Rous rat sarcomas. , 2009, Hereditas.
[34] C. Sarkar,et al. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours , 1997, Oncogene.
[35] M. Pillay,et al. Anomalies in direct pair-wise comparisons of RAPD fragments for genetic analysis. , 1995, BioTechniques.
[36] G. Reifenberger,et al. Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors , 2004, Acta Neuropathologica.
[37] R. Shatters,et al. Effect of transition interval between melting and annealing temperatures on RAPD analyses. , 1995, BioTechniques.
[38] Jing Yin,et al. Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction , 1993, Cancer.
[39] T. Mikkelsen,et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression , 1992, Nature.
[40] D. Dexter,et al. Heterogeneity of tumor cells from a single mouse mammary tumor. , 1978, Cancer research.
[41] C. Sarkar,et al. Genetic alterations in brain tumors identified by RAPD analysis. , 1998, Gene.
[42] G. Neal,et al. Monoclonal antibody against tumour‐derived cell line shows heterogeneity of altered hepatocytes during afb1‐induced carcinogenesis , 1984, International journal of cancer.
[43] M. Hamou,et al. Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas , 2005, Acta Neurochirurgica.
[44] F. Mitelman,et al. Tumor Etiology and Chromosome Pattern , 1972, Science.
[45] D. Ellsworth,et al. Artifactual variation in randomly amplified polymorphic DNA banding patterns. , 1993, BioTechniques.
[46] Thomas Boehm,et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.